Genomics, Cancer Care and Advocacy
by S.F. Terry, K. Zeitz, M.A. Majumder, P.F. Terry
Publisher: Genetic Alliance 2006
Number of pages: 29
In the past several decades, oncologists and cancer researchers have come to recognize the importance of the role of advocacy organizations in cancer research and treatment. With genomics poised to become a major force in cancer care, advocacy organizations have an important role to play in traditional areas of concern such as patient education about new genomic technologies.
Home page url
Download or read it online for free here:
by Douglas L. Riegert-Johnson - NCBI
Written as a comprehensive reference, it will be a useful reference for clinicians and researchers. This release includes chapters on Peutz-Jeghers Syndrome, Familial Atypical Multiple Mole Melanoma Syndrome, and multiple endocrine neoplasia type 1.
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.
by Ke Xu (ed.) - InTech
Metastasis is the major cause of cancer-related death. The mechanism underlying metastasis is complicated and poorly understood. Recent advances in tumor metastasis research have led to improved diagnosis and clinical management of cancer.
by Robyn Dewis, Jonathan Gribbin - National Collaborating Centre for Cancer
This is a summary of the current information available regarding the epidemiology of breast cancer regionally, nationally and internationally. Its purpose is to provide the guidelines on early and locally advanced and advanced breast cancer.